Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 4;82(3):329–338. doi: 10.1016/j.jinf.2021.01.022

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 2 — Characteristics of immunocompromised patients with COVID-19 compared to the general population with COVID-19. Pooled prevalence estimates from multiple studies in HCT, SOT, A-CA, and P-CA patients for (Panel A) patient comorbidities, (Panel B) COVID-19 symptoms, and (Panel C) COVID-19 severity are depicted as dots with bars indicating the 95% confidence intervals. The vertical hatched line indicates the comparable pooled prevalence for the similar measure in the general population with 95% confidence intervals indicated by the gray box as reported by Pormohammad et al.¹²⁸ For Fig. 2C, data from the Pormohammad et al. meta-analysis only permitted pooled prevalence comparison for severe disease, not mild/moderate.